<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03110627</url>
  </required_header>
  <id_info>
    <org_study_id>Dx01</org_study_id>
    <nct_id>NCT03110627</nct_id>
  </id_info>
  <brief_title>Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead</brief_title>
  <acronym>Dx-AF</acronym>
  <official_title>Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead: The Dx-AF Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eugene Crystal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Applied Health Research Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Biotronik Canada Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on
      the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard
      indications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recipients of implantable defibrillators (ICD) are at high risk of developing both AF and
      stroke, given the presence of multiple cardiovascular risk factors. Oral anticoagulation can
      prevent most strokes in patients with AF; provided that AF is recognized before a stroke
      occurs. Up to about 40% of incident AF may be sub-clinical, producing minimal or no symptoms,
      or being too short to allow detection.

      DX AF is a prospective, randomized-controlled, open-label trial. Patients who are identified
      on clinical grounds for a single-chamber ICD will be randomized to a VDD ICD (experimental
      group) or single chamber ICD (control group).

      The study will compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the
      ability to diagnose silent AF in patients without prior AF receiving an ICD for standard
      indications.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 31, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>DX AF is a prospective, randomized-controlled, open-label trial. Patients who are identified on clinical grounds for a single-chamber ICD will randomized to a VDD ICD (experimental group) or single chamber ICD (control group).</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial Fibrillation or atrial flutter lasting at least 6 minutes</measure>
    <time_frame>During the entire time of follow up - 3 years</time_frame>
    <description>Atrial Fibrillation or atrial flutter lasting at least 6 minutes detected by the ICD, ECG, Holter monitor or telemetry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for any ICD lead repositioning or replacement</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumothorax</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New pericardial effusion</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac tamponade</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure-related death or wound infection</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">378</enrollment>
  <condition>Cardiac Arrhythmias</condition>
  <condition>Atrial Fibrillation and Flutter</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Implantable Cardioverter-Defibrillators</condition>
  <arm_group>
    <arm_group_label>VDD ICD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VDD ICD - A single-lead ICD system with the ability to sense atrial rhythm from the floating electrode (a VDD-ICD known as the DX) - Experimental group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VVI ICD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>VVI ICD - Single chamber ICD system - Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VDD ICD (experimental group)</intervention_name>
    <description>Patients who are identified on clinical grounds for a single-chamber ICD will randomized to a VDD ICD (experimental group) or single chamber ICD (control group).
The study will compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard indications.</description>
    <arm_group_label>VDD ICD</arm_group_label>
    <other_name>Experimental: DX ICD (experimental group)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Single chamber VVI ICD (control group)</intervention_name>
    <description>Patients who are identified on clinical grounds for a single-chamber ICD will randomized to a VDD ICD (experimental group) or single chamber ICD (control group).
The study will compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard indications.</description>
    <arm_group_label>VVI ICD</arm_group_label>
    <other_name>Control: Single chamber VVI ICD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with ischemic or non-ischemic cardiomyopathy,

          -  LVEF&lt;50%, scheduled for primary or secondary prevention ICD

          -  Treating physicians feel that the use of single chamber ICD is appropriate

          -  No ECG-documented history of AF or flutter

          -  Age &gt; 50 years

        Exclusion Criteria:

          -  Known AF or flutter

          -  Current use of class I or III anti-arrhythmic medications

          -  Participants unwilling to attend study follow-up visits, considered unreliable for
             compliance or with an anticipated life expectancy less than 3 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>51 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eugene Crystal, MD, FRCP(C)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Val Panzov, MD</last_name>
    <phone>416-864-6060</phone>
    <phone_ext>7125</phone_ext>
    <email>panzovV@smh.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5H 3V9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Himani Ferdinandis</last_name>
      <phone>780-735-5255</phone>
      <email>Himani.Ferdinandis@covenanthealth.ca</email>
    </contact>
    <investigator>
      <last_name>Randall Williams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vancouver Island Health Authority</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V8R 1J8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Parfett</last_name>
      <phone>250-595-0400</phone>
      <email>dparfett@catrials.org</email>
    </contact>
    <investigator>
      <last_name>Chris Lane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scarborough and Rouge Hospital - Centenary Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M1E 4B9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikhil Patil</last_name>
      <email>admin@carginc.ca</email>
    </contact>
    <investigator>
      <last_name>Amir Janmohamed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fahema Ahmadzai</last_name>
      <phone>416-340-4800</phone>
      <phone_ext>4571</phone_ext>
      <email>Fahema.Ahmadzai@sunnybrook.ca</email>
    </contact>
    <investigator>
      <last_name>Eugene Crystal, MD, FRCP(C)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IUCPQ - Institut universitaire de cardiologie et de pneumologie de Québec</name>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paule Banville</last_name>
      <phone>519-685-8500</phone>
      <phone_ext>35625</phone_ext>
      <email>paule.banville@criucpq.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Jean-François Sarrazin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HSCM - L'Hôpital du Sacré-Coeur de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Langlois</last_name>
      <phone>514-338-2222</phone>
      <phone_ext>3722</phone_ext>
      <email>a-langlois@crhsc.rtss.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Marcio Sturmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHUS - Centre Hospitalier Universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claude Jean</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>16317</phone_ext>
      <email>cjean.chus@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Félix Ayala-Paredes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>June 8, 2017</last_update_submitted>
  <last_update_submitted_qc>June 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>St. Michael's Hospital, Toronto</investigator_affiliation>
    <investigator_full_name>Eugene Crystal</investigator_full_name>
    <investigator_title>Director, Arrhythmia Services, Schulich Heart Centre; Sunnybrook Health Sciences Centre; Associate Professor of Medicine, University of Toronto</investigator_title>
  </responsible_party>
  <keyword>Single-chamber ICD (implantable cardioverter-defibrillator)</keyword>
  <keyword>Cardiac Arrhythmias</keyword>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Atrial flutter</keyword>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

